Home›Companies›Biotech & Pharma›Plexiform Biosciences

Plexiform Bioscience Inc.

Develops eye drops for people with retinal vascular diseases.

No LinkedIn page we could confirm. Why?
Updated Nov 17, 2026·Latest SEC filing Jul 18, 2025·Suggest an edit

About Plexiform Biosciences

Plexiform Biosciences is a private company based in Dover, Delaware, incorporated in 2024 in Delaware. It has reported $1,340,000 raised in one offering on Form D since December 2024. Its chief executive is Saad Ahmad.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 3, 2024Dec 17, 2024amended Jul 18, 2025$1,340,000of $2.2M target14$95,714EquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Plexiform Biosciences's Form D filed Jul 18, 2025.

Saad Ahmad
Saad Ahmad
Founder & CEO
On every Form D that Plexiform Biosciences has filed: 2 filings, from Dec 17, 2024 to Jul 18, 2025.

Sources

  1. SECPlexiform Bioscience Inc. Form D, filed Dec 17, 2024
  2. SECPlexiform Bioscience Inc. filing history